Cancer-Related Fatigue

The use of a visual analogue scale is recommended for recording the intensity of symptoms in the week leading up to the moment of inquiry

Markus Horneber; Irene Fischer; Fernando Dimeo; Jens Ulrich Rüffer; Joachim Weis


Scholarcy highlights

  • Many cancer patients suffer from cancerrelated fatigue both during and after their treatment
  • Many randomized trials and meta-analyses have documented the efficacy of pharmacological and non-pharmacological treatments for CRF
  • This article is based on a selective review of the pertinent literature, taking account of the guidelines of the National Comprehensive Cancer Network and the German College of General Practitioners and Family Physicians, as well as a consensus statement of Medical Clinic 5—Nuremberg Hospital: Internal Medicine, Oncology, Hematology: Dr med
  • Clinical features of cancer-related fatigue ● CRF involves a vicious circle of diminished physical performance, inactivity, avoidance of effort, absence of regeneration, helplessness, and depressed mood
  • Many studies have shown that physicians generally fail to ask cancer patients systematically about the symptoms and signs of CRF
  • Effective training involves elevating the heart rate to 70% to 80% of maximum
  • The use of visual analogue scales is recommended for assessing the degree to which CRF impairs the patient in various areas of everyday life; values of 5 and above are taken to imply a severe limitation of the patient’s
  • For many patients this means that they will have to endure arduous treatment regimens, and in addition may suffer long term sequelae subsequent to their illness and its treatment

Need more features? Save interactive summary cards to your Scholarcy Library.